U.S. markets closed

Outlook Therapeutics, Inc. (OTLK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4200-0.0600 (-2.42%)
At close: 4:00PM EDT
Sign in to post a message.
  • B
    Brit
    Up 5% in a dreadful market
    Bullish
  • B
    Brit
    Topline data could drop any day now
    Bullish
  • P
    Paul
    Your going to give me 2.20s again? Please, who do I send the tip to?
  • B
    BL
    man, this has been a rough few days, hopefully better days ahead soon 🙏
  • K
    KWESI
    this is WEBISTIC
  • P
    Park
    going to 4.5 ~ 5.0 soon...
    Bullish
  • B
    Brit
    I cashed in on my other holding and went all in OTLK for data release
    Bullish
  • B
    B
    From a chart technical standpoint OTLK reached an important milestone by closing above the $2.60 cap on the upper channel. Next range should see the stock trading between $2.72-$2.78 with periodic swings above/below that range with the upper channel capping around $2.80.

    Time value to FDA decision is still low meaning that traders may still have time to wait for better entry. The Russell event has yet to begin/peak with less then a handful of blocks totaling less than 500,000 shares crossed desks last week at a successively higher pps. This trend should begin ramping up over the coming trading sessions and we should see new/existing analyst recommendations and possible upgrades as we get closer to an update mid august.

    The addition of Mr. Trenary as CEO has many believing that OTLK isn’t in a great position to market their product alone and given Trenary’s prior MA experience, it appears to make sense that OTLK may pursue an MA opportunity if approval is achieved.

    Keep an eye on institutional ownership numbers as a signal that Russell is moving in. The number of holders should be increasing soon.

    Happy trading and glta. 👍
    Bullish
  • F
    FfcP
    Just bought @ 2.6$...mak me happy.
  • J
    JW Vulture Capital Group
    This is going to the moon already while $itrm is getting fuel? Should you cut your losses and take your chances here?
    Just asking.
    Bullish
  • A
    Android
    Its over until 2022
    Bearish
  • r
    raad
    Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer.
    Bullish
  • K
    KWESI
    Exercise price, last close and stock price $0.00 $0.32 $2.56 exercise price is still listed as 0
    https://stockmarketmba.com/listofwarrants.php
  • S
    Serene
    Was anticipating a move in price today due to Russell 2000 inclusion. But pre market looks :(
  • P
    Paul
    Almost time to load up some more
  • C
    Carlos
    Institutional buying going on, responding to Russell 2000 inclusion? Or perhaps leading up to the Q3 read out of NORSE TWO, anticipated regulatory approval & commercialization of OTLK's Lytenava product.

    Or maybe folks are anticipating announcement of their EU manufacturing partner?
    Bullish
  • T
    Tommy T
    What’s everyone feelin?
  • j
    joe
    U guys still holding this?
  • J
    JW Vulture Capital Group
    Russell wants it cheap of course. You should have all added like Russell. LOL
  • h
    h@$33b g!
    Next week $3.50